ios 11212 has been researched along with 3-(2,2,2-trimethylhydrazine)propionate in 1 studies
| Studies (ios 11212) | Trials (ios 11212) | Recent Studies (post-2010) (ios 11212) | Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) |
|---|---|---|---|---|---|
| 30 | 0 | 6 | 251 | 35 | 105 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duburs, G; Isajevs, S; Kalvinsh, I; Klusa, V; Pupure, J; Rumaks, J; Svirskis, S | 1 |
1 other study(ies) available for ios 11212 and 3-(2,2,2-trimethylhydrazine)propionate
| Article | Year |
|---|---|
Search for stroke-protecting agents in endothelin-1-induced ischemic stroke model in rats.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelin-1; Male; Methylhydrazines; Neuroprotective Agents; Rats; Rats, Wistar; Stroke | 2012 |